Glaxo SmithKline borrows $9 billion

  Glaxo SmithKline's $9 billion bond issue today is the biggest by any U.S. company since 2002, and yields are dropping as investors line up to buy the drugmaker's debt. Bloomberg story here.

Continue Reading